Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Syros Pharmaceuticals Inc...

    NASDAQ: SYRS · Real-Time Price · USD
    0.03
    0.00 (19.52%)
    At close: Jun 09, 2025, 3:26 PM

    Syros Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.94M 14.88M 23.49M
    Cost of Revenue
    		 2.25M 2.97M n/a
    Gross Profit
    		 7.68M 11.91M 23.49M
    Operating Income
    		 -128.99M -135.87M -99.42M
    Interest Income
    		 6.82M 2.13M 87K
    Pretax Income
    		 -164.57M -94.65M -86.56M
    Net Income
    		 -164.57M -49.3M -90.47M
    Selling & General & Admin
    		 28.28M 29.3M 23.04M
    Research & Development
    		 108.15M 111.94M 99.87M
    Other Expenses
    		 n/a -9.51M n/a
    Operating Expenses
    		 138.92M 141.24M 122.91M
    Interest Expense
    		 5.13M 4.13M 3.91M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 138.92M 141.24M 122.91M
    Income Tax Expense
    		 n/a -45.35M 3.91M
    Shares Outstanding (Basic)
    		 28.33M 12.63M 6.25M
    Shares Outstanding (Diluted)
    		 28.33M 12.63M 6.25M
    EPS (Basic)
    		 -5.81 -3.9 -14.47
    EPS (Diluted)
    		 -5.81 -3.9 -14.47
    EBITDA
    		 -157.19M -87.55M -79.63M
    EBIT
    		 -159.45M -90.52M -82.65M
    Depreciation & Amortization
    		 2.25M 2.97M 3.02M

    Add to Watchlist